Investigation on nutritional risk assessment and nutritional support status of surgical patients with colorectal cancer.
To investigate the malnutrition, the incidence of nutritional risk and the application of nutritional support for patients with colorectal cancer, so as to provide a basis for the rational clinical application of nutritional support. A total of 264 surgical patients with colorectal cancer treated/followed up from January 2016 to March 2017 in Beijing Chaoyang Hospital were selected. The nutritional risk was assessed using the Nutritional Risk Screening 2002 (NRS2002), and the nutritional risk and application of nutritional support for patients with different gender, age and clinical disease stage were analyzed; the hospitalization duration and postoperative complications were also analyzed and compared. According to NRS2002, malnutrition accounted for 6.06% and nutrition risk accounted for 79.55%. There was no statistically significant difference in the nutritional risk between patients with different gender (p=0.059), the nutritional risk of the elderly patients (≥60 years) was higher than that of the non-elderly patients (<60 years) (p<0.001), and the nutritional risk among patients with different clinical stages had no statistically significant difference (p=0.654). All patients received nutritional support; the parenteral nutrition (PN) support rate was 39.02%, while PN+enteral nutrition (EN) support rate was 60.98%, while there was no patient receiving complete EN support. There was no statistically significant difference in the incidence rates of postoperative complications between patients with and without nutritional risk (p=0.546), but there was a statistically significant difference in the hospitalization duration between patients with and without nutritional risk (p=0.019). The incidence rates of malnutrition and nutritional risk are high in patients with colorectal cancer and the incidence of nutritional risk is related to age. The application of NRS2002 in nutritional risk screening for patients with colorectal cancer can provide a reasonable and effective basis for the clinical nutritional support.